Fulcrum Therapeutics
FULC
FULC
108 hedge funds and large institutions have $918M invested in Fulcrum Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
2% less funds holding
Funds holding: 110 → 108 (-2)
24% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 38
Holders
108
Holding in Top 10
4
Calls
$5.89M
Puts
$1.56M
Top Buyers
| 1 | +$81.7M | |
| 2 | +$24.1M | |
| 3 | +$7.45M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$5.62M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.44M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$11.9M | |
| 3 | -$9.18M | |
| 4 |
D.E. Shaw & Co
New York
|
-$7.21M |
| 5 |
Two Sigma Advisers
New York
|
-$6.94M |